Skip to content

A prospective study of subclinical atherosclerosis patients with hyperuricemia

A prospective study of subclinical atherosclerosis patients with hyperuricemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050192
Enrollment
Unknown
Registered
2021-08-21
Start date
2015-01-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperuricemia

Interventions

high serum uric acid level group :Nil
no high serum uric acid group:Nil

Sponsors

Huadong Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 50 to 90 years, male; 2. The subjects must voluntarily participate in the study and abide by the study regulations, understand and abide by the follow-up plan, and voluntarily sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and psychotic patients; 2. Patients with secondary hyperuricemia, such as leukemia, myeloma, renal failure, polycystic kidney, some endocrine diseases, and hyperuricemia caused by some drugs such as diuretics, aspirin and anti tuberculosis drugs; 3. The information is incomplete or safety judgment.

Design outcomes

Primary

MeasureTime frame
Serum uric acid;

Countries

China

Contacts

Public ContactWang Xiaojun

Huadong Hospital

13681803275@163.com+86 13681803275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026